FDA Inspection 696431 — DeGowin Blood Center

DeGowin Blood Center — FEI 1972918

The FDA completed an inspection of DeGowin Blood Center on November 3, 2010 in Iowa City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 3, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Iowa City, IA (United States)